1
|
Zorz A, Calderoni F, Castriconi R, di Franco F, Felisi M, Gallo P, Itta F, Longo M, Manco L, Milazzo O, Savini A, Cavedon C, Maffei N. The Italian young medical physicist scenario: Results from the young AIFM group survey. Phys Med 2023; 112:102633. [PMID: 37423002 DOI: 10.1016/j.ejmp.2023.102633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Accepted: 06/28/2023] [Indexed: 07/11/2023] Open
Abstract
PURPOSE The young working group of the Italian Association of Medical and Health Physics (AIFM) designed a survey to assess the current situation of the under 35 AIFM members. METHODS An online survey including 65 questions was designed to gather personal information, educational issues, working and research experience, and to evaluate the AIFM activities. The survey was distributed to the under 35 members between November 2022 and February 2023, through the young AIFM mailing list and social media. RESULTS 160 answers from 230 affiliates (70%, 31 years median age) were obtained. The results highlighted that 87% of the respondents had a fixed term/permanent employment, mainly in public hospitals (58%). Regarding Medical Physicists (MPs) training, 54% of the students left their region of origin due to the training plan (40%) and the availability of scholarships (25%) in the chosen university. Most of the respondents have no Radiation Protection Expert title, while the remaining 20%, 6%, and 3% are qualified to the first, second, and third level, respectively. Several young MPs (62.2%) were involved in research activities; however, only 28% had teaching experience, mainly within their workplace (20%, safety courses), during AIFM courses (4%), or university lectures (3%). CONCLUSIONS This survey reported the current situation of the under 35 AIFM members, highlighting the "brain drain" phenomenon from the south to the north of Italy, mainly due to the lack of post-graduate schools, scholarships, and job opportunities. The obtained results will help the future working program of the AIFM.
Collapse
Affiliation(s)
- Alessandra Zorz
- Medical Physics Department, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
| | | | - Roberta Castriconi
- Medical Physics Department, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Francesca di Franco
- Université Grenoble Alpes, CNRS, Grenoble INP, Institute of Engineering Univ. Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - Marco Felisi
- Medical Physics Department, ASST GOM Niguarda, Milan, Italy
| | | | - Francesca Itta
- Medical Physics Department, S.G. Moscati Hospital, Taranto, Italy
| | | | - Luigi Manco
- Medical Physics Unit, Azienda USL of Ferrara, 44124 Ferrara, Italy
| | - Olga Milazzo
- Department of Physics and Chemistry, University of Palermo, 90128 Palermo, Italy
| | | | - Carlo Cavedon
- Medical Physics Department, Azienda Ospedaliera Universitaria Integrata Verona, Italy
| | - Nicola Maffei
- Medical Physics Department, Azienda Ospedaliero-Universitaria di Modena, Italy.
| |
Collapse
|
2
|
Dieci MV, Massari F, Giusti R, Inno A, Lombardi G, Noto L, Passaro A, Pietrantonio F, Spada F, Valente M, Di Maio M, Torri V. Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM). ESMO Open 2018; 3:e000389. [PMID: 30425842 PMCID: PMC6212682 DOI: 10.1136/esmoopen-2018-000389] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Revised: 05/19/2018] [Accepted: 05/23/2018] [Indexed: 11/20/2022] Open
Abstract
BACKGROUND The professional gender gap is increasingly recognised in oncology. We explored gender issues perception and gender influence on professional satisfaction/gratification among young Italian oncologists. METHODS Italian oncologists aged ≤40 years and members of the Italian Association of Medical Oncology were invited to participate in an online survey addressing workload/burnout, satisfaction in professional abilities and relations, relevant factors for professional gratification, and gender barriers. χ2 test for general association or χ2 test for trend was used to analyse the data. RESULTS 201 young oncologists participated in the survey: 67% female, 71% aged 30-40 years, 41% still in training and 82% without children. Women and men were equally poorly satisfied by the relations with people occupying superior hierarchical positions. There was heterogeneity between women and men in current (p=0.011) and expected future (p=0.007) satisfaction in professional abilities: women were more satisfied by current empathy and relations with colleagues and were more confident in their future managerial and team leader skills. The most important elements for professional gratification indicated by all participants were, in general, work-life balance (36%) and intellectual stimulation/research (32%); specifically for women, work-life balance (48%) and intellectual stimulation/research (20%); and specifically for men, career (29%) and social prestige/recognition (26%). Heterogeneity within the same gender emerged. For example, the elements indicated by men as the most important were intellectual stimulation/research (39%) and work-life balance (21%) in general, versus social prestige/recognition (24%) and career (24%), respectively, specifically for men (p<0.0001). More women versus men perceived gender issue as an actual problem (60% vs 38%, p=0.03); men underestimated gender barriers to women's career (p=0.011). CONCLUSIONS Satisfaction in professional abilities varied by gender. Work-life balance is important for both women and men. Stereotypes about gender issues may be present. Gender issue is an actual problem for young oncologists, mostly perceived by women.
Collapse
Affiliation(s)
- Maria Vittoria Dieci
- Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy
- Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy
| | | | - Raffaele Giusti
- Medical Oncology Unit, Sant'Andrea Hospital of Rome, Roma, Italy
| | - Alessandro Inno
- Medical Oncology Unit, Cancer Care Center, Ospedale Sacro Cuore Don Calabria, Verona, Italy
| | - Giuseppe Lombardi
- Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy
| | - Laura Noto
- Oncology Unit, Aziende Socio Sanitarie Territoriali di Vimercate, Monza-Brianza, Italy
| | - Antonio Passaro
- Division of Thoracic Oncology, European Institute of Oncology, Milano, Italy
| | - Filippo Pietrantonio
- Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
- Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy
| | - Francesca Spada
- Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumor, European Institute of Oncology, Milano, Italy
| | - Monica Valente
- Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
| | - Massimo Di Maio
- Division of Medical Oncology, 'Ordine Mauriziano' Hospital, Torino, Italy
- Department of Oncology, University of Turin, Turin, Italy
| | - Valter Torri
- Laboratory of Methodology for Biomedical Research, IRCCS Mario Negri Institute for Pharmacological Research, Milan, Italy
| |
Collapse
|
3
|
Morgan G, Lambertini M, Kourie HR, Amaral T, Argiles G, Banerjee S, Cardone C, Corral J, De Mattos-Arruda L, Öztürk A, Petrova M, Poulsen L, Strijbos M, Tyulyandina A, Vidra R, Califano R, de Azambuja E, Garrido Lopez P, Guarneri V, Reck M, Moiseyenko V, Martinelli E, Douillard JY, Stahel R, Voest E, Arnold D, Cardoso F, Casali P, Cervantes A, Eggermont AMM, Eniu A, Jassem J, Pentheroudakis G, Peters S, McGregor K, Rauh S, Zielinski CC, Ciardiello F, Tabernero J, Preusser M. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open 2016; 1:e000107. [PMID: 28255451 PMCID: PMC5174792 DOI: 10.1136/esmoopen-2016-000107] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2016] [Accepted: 11/01/2016] [Indexed: 11/03/2022] Open
Abstract
The European Society for Medical Oncology (ESMO) is one of the leading societies of oncology professionals in the world. Approximately 30% of the 13 000 ESMO members are below the age of 40 and thus meet the society's definition of young oncologists (YOs). ESMO has identified the training and development of YOs as a priority and has therefore established a comprehensive career development programme. This includes a leadership development programme to help identify and develop the future leaders in oncology. Well-trained and highly motivated future generations of multidisciplinary oncologists are essential to ensure the optimal evolution of the field of oncology with the ultimate goal of providing the best possible care to patients with cancer. ESMO's career development portfolio is managed and continuously optimised by several dedicated committees composed of ESMO officers and is directly supervised by the ESMO Executive Board and the ESMO President. It offers unique resources for YOs at all stages of training and includes a broad variety of fellowship opportunities, educational courses, scientific meetings, publications and resources. In this article, we provide an overview of the activities and career development opportunities provided by ESMO to the next generation of oncologists.
Collapse
Affiliation(s)
- Gilberto Morgan
- Department of Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Oncology, Skåne University Hospital, Lund, Sweden
| | - Matteo Lambertini
- Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST,Genova, Italy
| | | | - Teresa Amaral
- Portuguese Air Force Health Direction, Lisbon, Portugal; Department of Dermatology, Center for Dermatooncology, Tübingen, Germany
| | - Guillem Argiles
- Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain
| | - Susana Banerjee
- Department of Medical Oncology, The Royal Marsden Hospital, London, UK
| | - Claudia Cardone
- Department of Medical Oncology, Second University of Naples, Naples, Italy
| | - Jesus Corral
- Department of Oncology, Virgen del Rocio University Hospital,Sevilla, Spain
| | | | - Akif Öztürk
- Department of Medical Oncology, American Hospital,Istanbul, Turkey
| | - Mila Petrova
- Department of Medical Oncology, Nadezhda Hospital,Sofia, Bulgaria
| | - Laurids Poulsen
- Department of Oncology, Aalborg University Hospital,Aalborg, Denmark
| | | | | | - Radu Vidra
- Department of Oncology, The Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj Napoca, Romania
| | - Raffaele Califano
- Department of Medical Oncology, The Christie NHS Foundation Trust,Manchester, UK
| | | | | | - Valentina Guarneri
- Department of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, University of Padova, Padova, Italy
| | - Martin Reck
- Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Grosshansdorf, Germany
| | - Vladimir Moiseyenko
- St. Petersburg Clinical and Scientific Oncological Center,St. Petersburg, Russian Federation
| | - Erika Martinelli
- U.O.C Oncologia Medica ed Ematologia Dipartimento Medico-Chrirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Naples, Italy
| | | | - Rolf Stahel
- University Hospital Zurich, Zurich, Switzerland
| | - Emile Voest
- Netherlands Cancer Institute, Amsterdam, The Netherlands
| | - Dirk Arnold
- Department of Medical Oncology, Klinik für Tumorbiologie, Freiburg, Germany
| | - Fatima Cardoso
- Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal
| | | | - Andrés Cervantes
- Department of Hematology and Clinical Oncology, University of Valencia, Valencia, Spain
| | | | - Alexandru Eniu
- Department of Oncology, The Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj Napoca, Romania
| | - Jacek Jassem
- Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
| | | | - Solange Peters
- Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Centre Pluridisciplinaire d'Oncologie, Lausanne, Switzerland
| | | | - Stefan Rauh
- Department of Hematology and Oncology, Centre Hospitalier Emile Mayrisch, Differdange et Esch Grand Duchy of Luxembourg, Esch/Alzette, Luxembourg
| | - Christoph C Zielinski
- Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria
| | | | - Josep Tabernero
- Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain
| | - Matthias Preusser
- Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
| |
Collapse
|